
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis
Yawen Jiang, Weiyi Ni, Jing Wu
BMJ Open (2019) Vol. 9, Iss. 11, pp. e031186-e031186
Open Access | Times Cited: 16
Yawen Jiang, Weiyi Ni, Jing Wu
BMJ Open (2019) Vol. 9, Iss. 11, pp. e031186-e031186
Open Access | Times Cited: 16
Showing 16 citing articles:
Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model
Liangru Zhou, Baiyang Gu, Jian Wang, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Liangru Zhou, Baiyang Gu, Jian Wang, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling study
Meng Gao, Shangying Hu, Xuelian Zhao, et al.
The Lancet Regional Health - Western Pacific (2025) Vol. 56, pp. 101499-101499
Open Access
Meng Gao, Shangying Hu, Xuelian Zhao, et al.
The Lancet Regional Health - Western Pacific (2025) Vol. 56, pp. 101499-101499
Open Access
Modelling epidemiological and economics processes – the case of cervical cancer
F Taeger, Lena Mende, Steffen Fleßa
Health Economics Review (2025) Vol. 15, Iss. 1
Open Access
F Taeger, Lena Mende, Steffen Fleßa
Health Economics Review (2025) Vol. 15, Iss. 1
Open Access
Projections of cancer mortality by 2025 in central China: A modeling study of global burden of disease 2019
Qiaohua Xu, Maigeng Zhou, Peng Yin, et al.
Heliyon (2023) Vol. 9, Iss. 2, pp. e13432-e13432
Open Access | Times Cited: 10
Qiaohua Xu, Maigeng Zhou, Peng Yin, et al.
Heliyon (2023) Vol. 9, Iss. 2, pp. e13432-e13432
Open Access | Times Cited: 10
Clearance of human papillomavirus infection in patients with cervical intraepithelial neoplasia
Ying Xiong, Liuyang Cui, Ce Bian, et al.
Medicine (2020) Vol. 99, Iss. 46, pp. e23155-e23155
Open Access | Times Cited: 23
Ying Xiong, Liuyang Cui, Ce Bian, et al.
Medicine (2020) Vol. 99, Iss. 46, pp. e23155-e23155
Open Access | Times Cited: 23
Nationwide Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection in China
Zhengyu Zeng, R. Marshall Austin, Lin Wang, et al.
American Journal of Clinical Pathology (2021) Vol. 157, Iss. 5, pp. 718-723
Closed Access | Times Cited: 19
Zhengyu Zeng, R. Marshall Austin, Lin Wang, et al.
American Journal of Clinical Pathology (2021) Vol. 157, Iss. 5, pp. 718-723
Closed Access | Times Cited: 19
Informing HPV vaccine pricing for government-funded vaccination in mainland China: a modelling study
Tingting You, Xuelian Zhao, Chenghao Pan, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 52, pp. 101209-101209
Open Access | Times Cited: 2
Tingting You, Xuelian Zhao, Chenghao Pan, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 52, pp. 101209-101209
Open Access | Times Cited: 2
Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
Daniel Tobias Michaeli, Sophia Stoycheva, Simon Mashudu Marcus, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 4, pp. 333-343
Open Access | Times Cited: 9
Daniel Tobias Michaeli, Sophia Stoycheva, Simon Mashudu Marcus, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 4, pp. 333-343
Open Access | Times Cited: 9
Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia
Abrham Wondimu, Maarten J. Postma, Marinus van Hulst
Vaccine (2022) Vol. 40, Iss. 14, pp. 2161-2167
Open Access | Times Cited: 8
Abrham Wondimu, Maarten J. Postma, Marinus van Hulst
Vaccine (2022) Vol. 40, Iss. 14, pp. 2161-2167
Open Access | Times Cited: 8
Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women
Xiaomeng Ma, Katherine Harripersaud, M. Kumi Smith, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 4, pp. 1073-1082
Open Access | Times Cited: 12
Xiaomeng Ma, Katherine Harripersaud, M. Kumi Smith, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 4, pp. 1073-1082
Open Access | Times Cited: 12
Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies
Wenchuan Shi, Xiaoli Cheng, Haitao Wang, et al.
BMJ Open (2021) Vol. 11, Iss. 12, pp. e052682-e052682
Open Access | Times Cited: 10
Wenchuan Shi, Xiaoli Cheng, Haitao Wang, et al.
BMJ Open (2021) Vol. 11, Iss. 12, pp. e052682-e052682
Open Access | Times Cited: 10
The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
Ke Zhu, Yuke Tian, Xiaomei Dong, et al.
Archives of Gynecology and Obstetrics (2022) Vol. 306, Iss. 1, pp. 173-187
Closed Access | Times Cited: 5
Ke Zhu, Yuke Tian, Xiaomei Dong, et al.
Archives of Gynecology and Obstetrics (2022) Vol. 306, Iss. 1, pp. 173-187
Closed Access | Times Cited: 5
The Cost-Effectiveness of HPV Vaccination in Asia Pacific Countries: What Lessons Can Indonesia Learn? – A Systematic Review
Suzanna Mongan, Joshua Byrnes, Han‐Soo Kim
(2024)
Closed Access
Suzanna Mongan, Joshua Byrnes, Han‐Soo Kim
(2024)
Closed Access
Uptake and determinants of HPV vaccination in South Asia: a systematic review and meta-analysis
Khola Noreen, Samina Naeem Khalid, Manal Abdulaziz Murad, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
Khola Noreen, Samina Naeem Khalid, Manal Abdulaziz Murad, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
9-valent HPV vaccine not cost effective in China
PharmacoEconomics & Outcomes News (2019) Vol. 843, Iss. 1, pp. 2-2
Closed Access
PharmacoEconomics & Outcomes News (2019) Vol. 843, Iss. 1, pp. 2-2
Closed Access